Liposomal and Enhanced Delivery: When It Matters
Delivery enhancement matters decisively for a few compounds and not at all for most, and the distinction is whether absorption was the limiting factor.
The Short Answer
Enhanced delivery is applied indiscriminately across the supplement market and matters for a small number of compounds. The question that separates them is simple: was absorption the limiting factor? For curcumin, whose plain form is very poorly absorbed, enhancement is the difference between a trial result and nothing. For vitamin C, which is already well absorbed at ordinary doses, liposomal formulation is solving a problem that does not exist.
The Enhancement Technologies
Liposomal. The compound is encapsulated in phospholipid vesicles, proposed to improve absorption and to protect the compound through the gut. Genuinely useful for some compounds, and the term is applied loosely, with many products described as liposomal being simple phospholipid mixtures rather than characterised liposomes.
Phytosome and phospholipid complex. The compound is complexed with phospholipids, with reasonable pharmacokinetic data for several botanical compounds including curcumin and silymarin.
Micellar and nanoemulsion. The compound is dispersed in surfactant micelles, improving solubility for lipophilic compounds. Well-characterised improvements for curcumin and some carotenoids.
Piperine co-administration. Black pepper extract inhibits glucuronidation and P-glycoprotein, raising plasma levels of several compounds including curcumin. Effective, and it also raises levels of some medications, which is an interaction risk rather than a neutral addition.
Cyclodextrin complexation and solid dispersions, improving solubility.
Sublingual and buccal, bypassing first-pass metabolism for some compounds and largely ineffective for large molecules.
The question for each is not whether the technology works in principle but whether the specific compound needed it.
Where It Genuinely Matters
| Compound | Why enhancement matters |
|---|---|
| Curcumin | Plain form very poorly absorbed and rapidly conjugated; trial results come from enhanced formulations |
| Coenzyme Q10 | Poorly water-soluble; solubilised and ubiquinol forms absorb better |
| Fat-soluble vitamins in malabsorption | Where fat absorption is impaired, water-miscible forms have a clinical rationale |
| Resveratrol and quercetin | Extensive conjugation; enhancement raises levels, though whether it reaches useful concentrations is unresolved |
| Berberine | Poor and variable bioavailability; enhanced forms exist and the trial base used plain berberine |
| Silymarin | Phospholipid complexes have established pharmacokinetic improvements |
| Astaxanthin and carotenoids | Lipophilic; formulation and dietary fat both matter |
Curcumin is the clearest case and worth stating plainly: the osteoarthritis and inflammatory marker trials used bioavailability-enhanced formulations, so a plain curcumin or turmeric powder product is not the studied intervention. Here the enhancement is not a premium feature, it is the product.
The resveratrol row illustrates the limit of the argument. Enhancement raises plasma levels, and whether it raises them to the concentrations used in the cell-culture work that motivated the compound is a separate and unresolved question. Better absorption of something that needs an unreachable concentration may still not be enough.
Where It Does Not Matter
Vitamin C. Well absorbed at ordinary doses through active transport, with absorption falling at high doses because the transporters saturate. Liposomal formulations may raise plasma levels beyond that ceiling, and whether higher plasma vitamin C produces any benefit is unestablished, since the outcome trials of high-dose vitamin C were unimpressive.
Creatine monohydrate. Nearly completely absorbed. Every alternative form, including those marketed on absorption, has failed to demonstrate superiority.
Most B vitamins, well absorbed in standard forms.
Magnesium, where the form affects tolerance and absorption, and the enhancement premium is unnecessary since glycinate and citrate are inexpensive.
Glutathione, oral. Extensively marketed in liposomal form. Oral glutathione is broken down and the evidence that any oral form meaningfully raises tissue glutathione is limited; N-acetylcysteine as a precursor has a better rationale.
NAD+ itself. No delivery technology addresses the fundamental problem, which is that the molecule does not cross cell membranes intact. It is degraded to precursors regardless of how it is packaged.
Collagen peptides, already hydrolysed to absorbable size.
The pattern: where a compound is already well absorbed, enhancement adds cost and not effect.
How to Evaluate an Enhancement Claim
Ask what the plain form's bioavailability is. If it is good, enhancement is unnecessary. This single question resolves most cases.
Ask whether the trials used the enhanced form. For curcumin they did, which makes enhancement necessary. For most compounds they did not, which means the enhanced version is untested rather than better.
Ask whether higher plasma levels have been shown to help. Raising levels is a pharmacokinetic result, not an outcome. High-dose vitamin C is the cautionary example: liposomal delivery may raise levels and the outcome trials at high doses were unimpressive regardless.
Ask whether it is characterised. Liposomal is used loosely, and many products described that way are phospholipid mixtures without documented vesicle formation or stability data.
Ask about the cost multiple. Enhanced forms frequently cost several times the plain form, which is justified for curcumin and rarely elsewhere.
Check for interaction consequences. Piperine raises plasma levels of several medications by the same mechanism it uses on curcumin, which makes it an interaction risk rather than a neutral enhancer.
Consider the free alternative. Taking a fat-soluble compound with a fat-containing meal improves absorption substantially at no cost, and it is the most reliable enhancement available.
The Practical Position
Pay for enhancement where the trials used it: curcumin above all, and it is not optional there. Solubilised or ubiquinol CoQ10 is reasonable.
Do not pay for it on vitamin C, creatine, B vitamins, magnesium, collagen peptides, or oral glutathione.
Use the free enhancements first. Fat-soluble compounds with a fat-containing meal. Iron with vitamin C and away from calcium, tea and coffee. Alternate-day iron dosing, which achieves higher fractional absorption than daily. These are more reliable than most paid enhancements.
Be sceptical of liposomal as a general premium, particularly where the term is unaccompanied by characterisation data.
Remember that better absorption is not better outcome. A compound that needs an unreachable concentration may remain out of reach even with enhancement, which is the position of most of the polyphenol category.
And remember what enhancement cannot fix: a compound with no human outcome evidence remains unevidenced no matter how well it is absorbed. Delivery addresses one of the seven filters between a paper and a recommendation, and passing it does not pass the others.
The AEONNN Perspective
Delivery enhancement is a Pharmacokinetics layer question, and it resolves with a single test: was absorption the limiting factor? For curcumin it was, decisively, since plain curcumin is very poorly absorbed and every positive trial used an enhanced formulation. There enhancement is not a premium feature but the product itself.
For most compounds it was not. Vitamin C is well absorbed at ordinary doses through saturable transport, creatine monohydrate is nearly completely absorbed, and B vitamins and magnesium have inexpensive well-absorbed forms. Enhancement there adds cost without effect, and the platform does not recommend paying for it.
Two limits the platform states explicitly. Better absorption is not a better outcome: raising plasma levels of a compound whose useful concentration is unreachable, or whose outcome trials were unimpressive at high doses, does not produce a benefit. And enhancement addresses only one of the filters between a paper and a recommendation, so a compound with no human outcome evidence remains unevidenced however well it is delivered. The free enhancements, taking fat-soluble compounds with fat and alternate-day iron dosing, outperform most paid ones.
Pillar Matrix mapping
Database Matrix layers
- Pharmacokinetics Layer (HMDB, PubChem)
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Quality / Formulation Layer (ConsumerLab, Labdoor)
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
Frequently Asked
Does liposomal delivery work?
For some compounds, decisively. The question is whether absorption was the limiting factor, and for most well-absorbed compounds it was not, so enhancement adds cost without effect.
Which compounds genuinely need enhancement?
Curcumin above all, since plain curcumin is very poorly absorbed and every positive trial used an enhanced formulation. Coenzyme Q10 benefits from solubilised or ubiquinol forms.
Is liposomal vitamin C worth it?
Vitamin C is well absorbed at ordinary doses, absorption saturates at high doses, and whether higher plasma levels produce any benefit is unestablished since high-dose outcome trials were unimpressive.
Does enhancement help NAD+ supplements?
No delivery technology addresses the fundamental issue, which is that NAD+ does not cross cell membranes intact and is degraded to precursors regardless of packaging.
Is piperine a neutral addition?
No. It raises plasma levels of several medications by the same glucuronidation and P-glycoprotein mechanism it uses on curcumin, which makes it an interaction risk.
What is the cheapest enhancement?
Taking fat-soluble compounds with a fat-containing meal, iron with vitamin C away from calcium and tea, and alternate-day iron dosing, which achieves higher fractional absorption than daily.
Does better absorption mean a better outcome?
No. Raising levels is a pharmacokinetic result rather than an outcome, and a compound with no human outcome evidence remains unevidenced however well it is absorbed.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.